TherapeuticsMD (TXMD) Non-Current Receivables: 2022-2025
Historic Non-Current Receivables for TherapeuticsMD (TXMD) over the last 3 years, with Sep 2025 value amounting to $14.3 million.
- TherapeuticsMD's Non-Current Receivables fell 14.09% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year decrease of 14.09%. This contributed to the annual value of $16.0 million for FY2024, which is 13.38% down from last year.
- As of Q3 2025, TherapeuticsMD's Non-Current Receivables stood at $14.3 million, which was down 3.85% from $14.8 million recorded in Q2 2025.
- TherapeuticsMD's 5-year Non-Current Receivables high stood at $20.3 million for Q1 2023, and its period low was $14.3 million during Q3 2025.
- Its 3-year average for Non-Current Receivables is $17.3 million, with a median of $17.2 million in 2024.
- Data for TherapeuticsMD's Non-Current Receivables shows a maximum YoY fell of 14.09% (in 2025) over the last 5 years.
- Over the past 4 years, TherapeuticsMD's Non-Current Receivables (Quarterly) stood at $20.3 million in 2022, then fell by 8.73% to $18.5 million in 2023, then fell by 13.38% to $16.0 million in 2024, then declined by 14.09% to $14.3 million in 2025.
- Its last three reported values are $14.3 million in Q3 2025, $14.8 million for Q2 2025, and $15.4 million during Q1 2025.